Compare UBC Medical Indonesia Tbk. (LABS) vs Sinergi Multi Lestarindo Tbk. (SMLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp185 (market cap 444.68B, 19.41M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (19.41M versus 635.5K). Which is the better fit depends on your goals.
| LABS | SMLE | |
|---|---|---|
Market Cap | 691.25B | 444.68B |
Volume | 635.5K | 19.41M |
Lot | 6.36K | 194.13K |
Turnover | 110.15M | 3.66B |
Average Price | 173.33 | 188.72 |
Value | 110.15M | 3.66B |
Indicative Equilibrium Price | 174 | 185 |
Indicative Equilibrium Volume | 50 | 388 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Sinergi Multi Lestarindo Tbk.
PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →
